Home  >  News
Eppen_CellXpert_Mar2026
you can get e-magazine links on WhatsApp. Click here
News
Allergan Aesthetics redefines skin quality communication with launch of Skin Quality Index  March 17, 2026
ASPA–CRISIL “State of Counterfeiting in India 2025” report reveals counterfeit medicines account for around 28% of the market  March 17, 2026
Bayer announces finerenone meets primary endpoint in pivotal phase III FIND-CKD study in patients with non-diabetic chronic kidney disease  March 17, 2026
IIT Roorkee inaugurates Ashok Soota Molecular Medicine Facility at BSBE to advance translational biomedical research  March 17, 2026
Pulse of Positivity Health and Wellness Summit 2026 brings policymakers, doctors, to shape the future of health in India  March 17, 2026
Lupin and Zydus ink licensing agreement to co-market innovative semaglutide injection in India  March 17, 2026
Himachal Institute of Pharmacy hosts 2-day Intl Conference on Pharmacy Beyond Borders: Translating Innovation for Global Health  March 17, 2026
GN Store Nord enters into agreement to sell its hearing business to Amplifon for DKK 17.0 billion  March 17, 2026
Lundbeck to present phase 1b data on Lu AF28996, an investigational treatment for people with advanced Parkinson’s disease at the 2026 AD/PD conference  March 17, 2026
ZEISS India and Ashoka University Launch Professional Course in Advanced Microscopy (PCAM) 2026  March 17, 2026
First World Health Congress sees India to become a hub for global health collaboration  March 17, 2026
AstraZeneca’s Imfinzi in combo with standard-of-care FLOT chemotherapy gets European approval to treat patients with early gastric and gastroesophageal cancers  March 17, 2026
Samsung Bioepis and Epis NexLab ink research collaboration and license pact with G2GBIO to develop novel assets including long-acting semaglutide  March 17, 2026
US FDA accepts Sun Pharma’s sBLA for Ilumya to treat adults with active psoriatic arthritis  March 17, 2026
Eli Lilly’s phase 3 ADorable-1 trial of Ebglyss in paediatric patients with moderate-to-severe atopic dermatitis meets primary and key secondary endpoints  March 17, 2026
India’s Rs. 1,000 crore MedTech Fund signals strategic shift toward domestic manufacturing  March 17, 2026
 Back
 
Propak_Asia_2026
CP_CPHI_Korea2026
IWE_CP_2026
ChemExpo_India_2026
PharmaTech_expo_Chandigarh2026
ASIA_PHARMA_EXPO_2026
CPHI_Japan26
Ana_Lab_India_2026
PharmaCore_India_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram